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Adenosine has become widely used because of its diagnostic and therapeutic value in the emergency management of
arrhythmias. It produces transient heart block by slowing conduction through the A V node and thus terminates
supraventricular tachycardias that involve the atrioventricular node. Bradyarrhythmias of short duration are common
side effects of the use of this drug. Premature atrial and ventricular beats have also been reported. The very short
half-life and lack of serious adverse effects generally lead to the consideration that adenosine is a safe drug. We describe
a 56-year-old woman with a supraventricular tachycardia. To terminate this rhythm disorder intravenous adenosine was
given. Interruption of the supraventricular tachycardia was followed by non-sustained polymorphic ventricular
tachycardia.
Introduction
Adenosine is a rapidly metabolized endogenous purine
nucleoside that has recently become very useful for the
treatment and diagnosis of cardiac arrhythmias. It is
effective in terminating most supraventricular tachycar-
dias in which the AV node forms part of the reentrant
circuit. Additionally, it may unmask an underlying
atrial arrhythmia by slowing AV node conduction.
Due to the short half-life of adenosine its clinical side
effects last less than 1 min and serious haemodynamic
adverse effects are absent. Therefore, adenosine has
become the preferred drug, compared to verapamil or
beta-blockers, for terminating supraventricular tachy-
cardias1'1. Previously published review articles'2'31 men-
tioned that short runs of non-sustained ventricular
tachycardias seldom occur after administration of
adenosine. To our knowledge, only one study orig-
inally reported this rare arrhythmic phenomenon but
did not give a detailed description141. In the present
case we describe the occurrence of a polymorphic
non-sustained ventricular tachycardia after adenosine
was given to terminate an episode of supraventricular
tachycardia.
Case report
A 56-year-old woman was admitted because of a
recurrence of a paroxysmal supraventricular tachycar-
dia. The ECG recording on several occasions between
tachycardia episodes had always showed sinus rhythm
with normal PR and QTc intervals. Drug therapy
comprised verapamil 40 mg once daily and phenobar-
bital 20 mg. On admission, the patient complained of
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chest tightness and palpitations. Blood pressure was
110/80 mmHg, heart rate 180 beats . min ~ ', and physi-
cal examination showed no evidence of heart failure.
The ECG indicated the presence of AV nodal reentrant
tachycardia, and since the vagal manoeuvres failed to
terminate the tachycardia, adenosine was given as a
6 mg i.v. bolus. Immediately after successful termi-
nation of the supraventricular tachycardia, a poly-
morphic non-sustained ventricular tachycardia of 10
complexes (180 beats . min~ ') occurred (Fig. 1). Simul-
taneously the patient complained of transient light-
headedness and chest discomfort. Blood pressure was
not monitored. After resolution of the tachycardia the
repeated 12-lead ECG and a two-dimensional echo-
Doppler study showed no abnormality. Routine lab-
oratory tests were within normal limits. Neither a
bicycle exercise test nor an ambulatory electrocardio-
gram demonstrated any ventricular arrhythmias. The
patient refused to be rechallenged with another bolus
of adenosine while in stable sinus rhythm.
Discussion
Sinus bradycardia and bradyarrhythmias (transient
sinus arrest, complete heart block or asystole) may
follow adenosine administration. Premature isolated
atrial and ventricular complexes are often observed
after adenosine-induced termination of tachycardias'1'.
The rare occurrence of short runs of ventricular tachy-
cardias has been quoted'2'31, but no serious conse-
quences of this proarrhythmic effect have been
reported'4'. Despite extensive research on the cardiac
and cardiovascular effects of adenosine13', the patho-
physiological mechanism of the premature ventricular
contractions that develop after adenosine-induced ter-
mination of a supraventricular tachycardia remains
unknown. A direct myocardial proarrhythmic effect
seems unlikely because, in contrast to what is observed
0195-668X/94A)20279+O2 $08.00/0 '(, 1994 The European Society of Cardiology
282 M. Romer and R Candinas
Figure 1 Polymorphic non-sustained ventricular tachycardia following the termination of the supraventncular tachycardia after
adenosine was given. Paper speed is 25 mm . s~ '.
in supraventricular tissue, no direct effect of adenosine
(e.g. receptor-mediated activation of potassium chan-
nels) has been observed in ventricular myocytes[3].
However, adenosine activates autonomic reflex mech-
anism (by chemoreceptor stimulation) and increases
sympathetic tone151. Additional factors, such as the
unpleasant side effects of adenosine and the preceding
supraventricular tachycardia may contribute to raising
catecholamines levels and facilitating runs of ventricu-
lar extrasystole.
Conclusion
It is known that runs of ventricular premature beats
can initiate more severe and even fatal ventricular
tachyarrhythmias, especially in patients with organic
heart disease. Whatever may be the underlying mech-
anisms of adenosine-induced ventricular extrasystole,
our case illustrates a serious proarrhythmic effect of
adenosine. It has to be emphasized that potentially
lethal tachyarrhythmias may follow intravenous adeno-
sine. Thus, instruments for resuscitation, including a
DC-cardioverter, are mandatory when this drug is
administered.
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